Recent Updates
Recently added Catalysts
SRPT Positive Sentiment

Sarepta Therapeutics anuncia a los destinatarios de Route 79, el Programa de Becas de Duchenne, para el año académico 2026-2027

Tuesday, September 8, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Sarepta Therapeutics has announced the recipients of the Route 79 Duchenne scholarship program for the 2026-2027 academic year. A total of 25 scholarships will be awarded, with 20 going to individuals diagnosed with Duchenne muscular dystrophy and five to their siblings. This program, now in its ninth year, aims to support those affected by the condition.

Market Sentiment Analysis

POSITIVE FACTORS

  • Sarepta Therapeutics supports education for individuals affected by Duchenne.
  • The Route 79 scholarship program celebrates its ninth year.
  • Twenty scholarships are awarded to individuals with Duchenne.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+46%
120-day peak, hindsight
Typical move
16.8%
average across 4 past catalysts
Lead asset
Eteplirsen
Phase 3 · Muscular Dystrophy, Duchenne

Full Press Release Details

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), el líder en medicina genética de precisión para enfermedades raras, anunció hoy a los 25 destinatarios de Route 79, el programa de becas de Duchenne para el año académico 2026-2027. De las becas académicas, 20 se les concederán a personas con Duchenne y cinco a hermanos de personas con Duchenne. Hoy en su noveno año, el programa se creó para reconocer a las personas que viven con distrofia muscular de Duchenne mientras

Frequently Asked Questions

What is the Route 79 scholarship program?

The Route 79 scholarship program supports individuals affected by Duchenne muscular dystrophy.

How many scholarships are awarded in 2026-2027?

A total of 25 scholarships will be awarded for the academic year 2026-2027.

Who can apply for the Route 79 scholarships?

Twenty scholarships are for individuals with Duchenne, and five for their siblings.

How long has the Route 79 program been running?

The Route 79 scholarship program is now in its ninth year.

ShareAdd on Google
Tags: SRPT Viatris Investor Conferences Healthcare Sarepta Therapeutics Duchenne muscular dystrophy Route 79 scholarship recipients academic year 2026-2027
Last updated: Sep 8, 2026

Biotech snapshot

Cash runway
$788M liquidity · $0M/mo burn
Low dilution risk
Lead asset
EteplirsenPhase 3
Muscular Dystrophy, Duchenne →

Catalyst track record

+46%
best trade around SRPT's most recent catalyst

Peak hindsight return over a 120-day window, across 4 tracked FDA/PDUFA catalysts for SRPT.

See every catalyst's timing & PoA →